These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20459419)

  • 1. [Which of algorithms of warfarin dosing based on results of pharmacogenetic testing is suitable for patients in Russia].
    Sychev DA; Antonov IM; Kropacheva ES; Panchenko EP
    Kardiologiia; 2010; 50(4):35-7. PubMed ID: 20459419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticoagulant action and safety of warfarin dosing based on pharmacogenetic testing: results of the first Russian prospective pilot study].
    Sychev DA; Antonov IM; Ignat'ev IV; Naumova IuV; Dmitriev VA; Kropacheva ES; Dobrovol'skiĭ OB; Panchenko EP; Tashenova IA; Kukes VG
    Kardiologiia; 2010; 50(5):42-6. PubMed ID: 20831047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation.
    Cho HJ; On YK; Bang OY; Kim JW; Huh W; Ko JW; Kim JS; Lee SY
    Clin Ther; 2011 Oct; 33(10):1371-80. PubMed ID: 21981797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of pharmacogenetic-based dosing algorithms to identify older patients requiring low daily doses of warfarin.
    Schwartz JB; Kane L; Moore K; Wu AH
    J Am Med Dir Assoc; 2011 Nov; 12(9):633-8. PubMed ID: 21450231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin.
    Teh LK; Langmia IM; Fazleen Haslinda MH; Ngow HA; Roziah MJ; Harun R; Zakaria ZA; Salleh MZ
    J Clin Pharm Ther; 2012 Apr; 37(2):232-6. PubMed ID: 21507031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warfarin-dosing algorithm based on a population pharmacokinetic/pharmacodynamic model combined with Bayesian forecasting.
    Sasaki T; Tabuchi H; Higuchi S; Ieiri I
    Pharmacogenomics; 2009 Aug; 10(8):1257-66. PubMed ID: 19663670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of warfarin pharmacogenetic algorithms in clinical practice.
    Marin-Leblanc M; Perreault S; Bahroun I; Lapointe M; Mongrain I; Provost S; Turgeon J; Talajic M; Brugada R; Phillips M; Tardif JC; Dubé MP
    Pharmacogenomics; 2012 Jan; 13(1):21-9. PubMed ID: 22176621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin Dosing Algorithms Underpredict Dose Requirements in Patients Requiring ≥7 mg Daily: A Systematic Review and Meta-analysis.
    Saffian SM; Duffull SB; Wright D
    Clin Pharmacol Ther; 2017 Aug; 102(2):297-304. PubMed ID: 28160278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin Pharmacogenetics Reevaluated:  Subgroup Analysis Reveals a Likely Underestimation of the Maximum Pharmacogenetic Benefit by Clinical Trials.
    Stack G; Maurice CB
    Am J Clin Pathol; 2016 May; 145(5):671-86. PubMed ID: 27247371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of warfarin pharmacogenetic testing in clinical practice.
    Tan GM; Wu E; Lam YY; Yan BP
    Pharmacogenomics; 2010 Mar; 11(3):439-48. PubMed ID: 20402581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Performance of the Warfarin Pharmacogenetics Algorithms in Patients with Surgery of Heart Valve Replacement and Heart Valvuloplasty.
    Xu H; Su S; Tang W; Wei M; Wang T; Wang D; Ge W
    Thromb Res; 2015 Sep; 136(3):552-9. PubMed ID: 26188922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of Empiric and Pharmacogenetic Approaches in Assessment of Efficacy of Anticoagulant Therapy].
    Kokh NV; Slepukhina AA; Tsvetovskaya GA; Lifshits GA
    Kardiologiia; 2015; 55(4):57-60. PubMed ID: 26502504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients.
    Cho SM; Lee KY; Choi JR; Lee KA
    Yonsei Med J; 2016 May; 57(3):635-40. PubMed ID: 26996562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel individualized warfarin dose algorithm based on a population pharmacokinetic model with improved prediction accuracy for Chinese patients after heart valve replacement.
    Zhu YB; Hong XH; Wei M; Hu J; Chen X; Wang SK; Zhu JR; Yu F; Sun JG
    Acta Pharmacol Sin; 2017 Mar; 38(3):434-442. PubMed ID: 28216623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration.
    Santos PC; Marcatto LR; Duarte NE; Gadi Soares RA; Cassaro Strunz CM; Scanavacca M; Krieger JE; Pereira AC
    Pharmacogenomics; 2015 Jul; 16(8):865-76. PubMed ID: 26050796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic impact of VKORC1 and CYP2C9 allelic variants on warfarin dose requirements in a hispanic population isolate.
    Palacio L; Falla D; Tobon I; Mejia F; Lewis JE; Martinez AF; Arcos-Burgos M; Camargo M
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):83-90. PubMed ID: 19567378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations.
    Wu AH; Wang P; Smith A; Haller C; Drake K; Linder M; Valdes R
    Pharmacogenomics; 2008 Feb; 9(2):169-78. PubMed ID: 18370846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for Predicting Warfarin Dose Requirements.
    Saffian SM; Wright DF; Roberts RL; Duffull SB
    Ther Drug Monit; 2015 Aug; 37(4):531-8. PubMed ID: 25549208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial neural network-based pharmacogenomic algorithm for warfarin dose optimization.
    Pavani A; Naushad SM; Kumar RM; Srinath M; Malempati AR; Kutala VK
    Pharmacogenomics; 2016; 17(2):121-31. PubMed ID: 26666467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.